Post-therapeutic Surveillance Schedule for Oral Cancer: Is There Agreement?

Oral and Maxillofacial Surgery

Volumn 16, Issue 4, 2012, Pages 327-340

  Liu, Guicai ^a,b   Dierks, Eric J ^a,c,g   Bell, R Bryan ^a,c,d,e,f,g   Bui, Tuan G ^a,c,g   Potter, Bryce E ^a,c,h  

^a Head and Neck Surgical Associates   (United States)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d Providence Cancer Center   (United States)

^e EARLE A CHILES RESEARCH INSTITUTE   (United States)

^f PROVIDENCE PORTLAND MEDICAL CENTER   (United States)

^g LEGACY EMANUEL MEDICAL CENTER   (United States)

^h Legacy Emanuel Medical Center   (United States)

Author keywords

Follow up; Head and neck cancer; Oral cancer; Recurrence; Squamous cell carcinoma; Surveillance

Indexed keywords

ADJUVANT CHEMORADIOTHERAPY; ADJUVANT THERAPY; FOLLOW UP; HOSPITAL MANAGEMENT; HUMAN; METASTASIS; MOUTH TUMOR; NEEDS ASSESSMENT; PATHOLOGY; REVIEW; RISK ASSESSMENT; SQUAMOUS CELL CARCINOMA; TIME; TUMOR RECURRENCE;

APPOINTMENTS AND SCHEDULES; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY, ADJUVANT; FOLLOW-UP STUDIES; HUMANS; MOUTH NEOPLASMS; NEEDS ASSESSMENT; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; RISK ASSESSMENT; TIME FACTORS;

EID: 84869500224     PISSN: 18651550     EISSN: 18651569     Source Type: Journal    
DOI: 10.1007/s10006-012-0356-3     Document Type: Review

References (57)

1. Gilbert R, Devries-Aboud M, Winquist E, Waldron J, McQuestion M, Head and Neck Disease Site Group (2009) The management of head and neck cancer in Ontario: organizational and clinical practice guideline recommendations. Cancer Care Ontario (CCO), Toronto (ON), p 70.
2. Yuasa K, Kawazu T, Kunitake N, Uehara S, Omagari J, Yoshiura K, Nakayama E, Kanda S (2000) Sonography for the detection of cervical lymph node metastases among patients with tongue cancer: criteria for early detection and assessment of follow-up examination intervals. AJNR Am J Neuroradiol 21: 1127-1132.
3. National Comprehensive Cancer Network (2011) NCCN clinical practice guidelines in oncology, head and neck cancers, version 2. NCCN, Fort Washington, PA.
4. Roland NJ, Paleri V (eds) (2011) Head and neck cancer: multidisciplinary management guidelines, 4th edn. ENT UK, London, p 335.
5. British Association of Head and Neck Oncologists, Consensus Group Recommendation BAHNO (2001) Practice care guidance for clinicians participating in management of head and neck cancer patients in the UK. Drawn up by a consensus group of practicing clinicians. Eur J Surg Oncol 27(suppl A): S1-S17.
6. Boysen M (1994) Value of follow-up in patients treated for squamous cell carcinomas of the oral cavity and oropharynx. Recent Results Canc Res 134: 205-214.
7. Merkx MA, van Gulick JJ, Marres HA, Kaanders JH, Bruaset I, Verbeek A, de Wilde PC (2006) Effectiveness of routine follow-up of patients treated for T1-2 N0 oral squamous cell carcinomas of the floor of mouth and tongue. Head Neck 28: 1-7.
8. Wensing BM, Merkx MA, Krabbe PF, Marres HA, van den Hoogen FJ (2011) Oral squamous cell carcinoma and a clinically negative neck: the value of follow-up. Head Neck 33: 1400-1405.
9. de Visscher AV, Manni JJ (1994) Routine long-term follow-up in patients treated with curative intent for squamous cell carcinoma of the larynx, pharynx, and oral cavity: does it make sense? Arch Otolaryngol Head Neck Surg 120: 934-939.
10. Rivelli V, Luebbers HT, Weber FE, Cordella C, Grätz KW, Kruse AL (2011) Screening recurrence and lymph node metastases in head and neck cancer: the role of computer tomography in follow-up. Head & Neck Oncology 3: 18.
11. Johnson FE, Virgo KS, Clemente MF, Johnson MH, Paniello RC (1998) How tumor stage affects surgeons' surveillance strategies after surgery for carcinoma of the upper aerodigestive tract. Cancer 82: 1932-1937.
12. Gellrich NC, Schramm A, Böckmann R, Kugler J (2002) Follow-up in patients with oral cancer. J Oral Maxillofac Surg 60: 380-388.
13. Boysen M, Natvig K, Winther FO, Tausjö J (1985) Value of routine follow-up in patients treated for squamous cell carcinoma of the head and neck. J Otolaryngol 14: 211-214.
14. Ohkubo H, Maeda T, Hirano M, Kurita S, Mihashi S (1982) Carcinoma of the lip and oral cavity-a retrospective investigation of 113 patients. Kurume Med J 29(Suppl): S61-S78.
15. Snow GB (1992) Follow-up in patients treated for head and neck cancer: how frequent, how thorough and for how long? Eur J Cancer 28: 315-316.
16. Sasaki M, Aoki T, Karakida K, Otsuru M, Takahashi M, Akamatsu T, Sakamoto H, Ota Y (2011) Postoperative follow-up strategy in patients with oral squamous cell carcinoma. J Oral Maxillofac Surg 69: e105-e111.
17. Shingaki S, Takada M, Sasai K, Bibi R, Kobayashi T, Nomura T, Saito C (2003) Impact of lymph node metastasis on the pattern of failure and survival in oral carcinomas. Am J Surg 185: 278-284.
18. Marchant FE, Lowry LD, Moffitt JJ, Sabbagh R (1993) Current national trends in the posttreatment follow-up of patients with squamous cell carcinoma of the head and neck. Am J Otolaryngol 14: 88-93.
19. Kissun D, Magennis P, Lowe D, Brown JS, Vaughan ED, Rogers SN (2006) Timing and presentation of recurrent oral and oropharyngeal squamous cell carcinoma and awareness in the outpatient clinic. Br J Oral Maxillofac Surg 44: 371-376.
20. Cooney T, Poulsen M (1999) Is routine follow-up useful after combined-modality therapy for advanced head and neck cancer? Arch Otolaryngol Head Neck Surg 125: 379-382.
21. Boysen M, Lövdal O, Tausjö J, Winther F (1992) The value of follow-up in patients treated for squamous cell carcinoma of the head and neck. Eur J Cancer 28: 426-430.
22. Shaha AR, Patel S, Shasha D, Harrison LB (2001) Head and neck cancer: counterpoint. In: Lenhard RE Jr, Osteen RT, Gansler T (eds) Clinical oncology. The American Cancer Society, Inc, Atlanta, Georgia, pp 297-330.
23. Manikantan K, Dwivedi R, Sayed S, Pathak KA, Kazi R (2011) Current concepts of surveillance and its significance in head and neck cancer. Ann R Coll Surg Engl 93: 576-582.
24. Hsu YB, Chu PY, Liu JC, Lan MC, Chang SY, Tsai TL, Huang JL, Wang YF, Tai SK (2008) Role of chest computed tomography in head and neck cancer. Arch Otolaryngol Head Neck Surg 134: 1050-1054.
25. Stalpers LJA, van Vierzen PBJ, Brouns JJA, Bruaset I, Manni JJ, Verbeek AL, Ruys JH, van Daal WA (1989) The role of yearly chest radiography in the early detection of lung cancer following oral cancer. Int J Oral Maxillofac Surg 18: 99-103.
26. Li Z, Seah TE, Tang P, Ilankovan V (2011) Incidence of second primary tumors in patients with squamous cell carcinoma of the tongue. Br J Oral Maxillofac Surg 49: 50-52.
27. Baatenburg de Jong RJ, Rongen RJ, Harthoorn M, Verwoerd CD, Knegt P (1989) Metastatic neck disease: palpation vs. ultrasound examination. Arch Otolaryngol Head Neck Surg 115: 689-690.
28. Fruehwald FX (1988) Clinical examination, CT and US in tongue cancer staging. Eur J Radiol 8: 236-241.
29. Hayashi T, Ito J, Taira S, Katsura K, Shingaki S, Hoshina H (2003) The clinical significance of follow-up sonography in the detection of cervical lymph node metastases in patients with stage I or II squamous cell carcinoma of the tongue. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 96: 112-117.
30. Eida S, Sumi M, Yonetsu K, Nakamura T (2003) Combination of helical CT and Doppler sonography in the follow-up of patients with clinical N0 stage neck disease and oral cancer. AJNR Am J Neuroradiol 24: 312-318.
31. van den Brekel MWM, Castelijns JA, Stel HV, Luth WJ, Valk J, van der Waal I, Snow GB (1991) Occult metastatic neck disease: detection with US and US-guided fine-needle aspiration cytology. Radiology 180: 457-461.
32. van den Brekel MW, Stel HV, Castelijns JA, Croll GJ, Snow GB (1991) Lymph node staging in patients with clinically negative neck examinations by ultrasound and ultrasound-guided aspiration cytology. Am J Surg 162: 362-366.
33. van den Brekel MWM, Reitsma LC, Quak JJ, Smeele LE, van der Linden JC, Snow GB, Castelijns JA (1999) Sonographically guided aspiration cytology of neck nodes for selection of treatment and follow-up in patients with N0 head and neck cancer. AJNR Am J Neuroradiol 20: 1727-1731.
34. Lell M, Baum U, Greess H, Nömayr A, Nkenke E, Koester M, Lenz M, Bautz W (2000) Head and neck tumors: imaging recurrent tumor and post-therapeutic changes with CT and MRI. Eur J Radiol 33: 239-247.
35. Atula TS, Varpula MJ, Kurki TJ, Klemi PJ, Grénman R (1997) Assessment of cervical lymph node status in head and neck cancer patients: palpation, computed tomography and low field magnetic resonance imaging compared with ultrasound-guided fine-needle aspiration cytology. Eur J Radiol 25: 152-161.
36. de Bondt RB, Nelemans PJ, Hofman PA, Casselman JW, Kremer B, van Engelshoven JM, Beets-Tan RG (2007) Detection of lymph node metastases in head and neck cancer: a meta-analysis comparing US, USgFNAC, CT and MR imaging. Eur J Radiol 64: 266-272.
37. van den Brekel MW, Castelijns JA, Snow GB (1998) The size of lymph nodes in the neck on sonograms as a radiologic criterion for metastasis: how reliable is it? AJNR Am J Neuroradiol 19: 695-700.
38. Takes RP, Righi P, Meeuwis CA, Manni JJ, Knegt P, Marres HA, Spoelstra HA, de Boer MF, van der Mey AG, Bruaset I, Ball V, Weisberger E, Radpour S, Kruyt RH, Joosten FB, Laméris JS, van Oostayen JA, Kopecky K, Caldemeyer K, Henzen-Logmans SC, Wiersma-van Tilburg JM, Bosman FT, van Krieken JH, Hermans J, Baatenburg de Jong RJ (1998) The value of ultrasound with ultrasound-guided fine-needle aspiration biopsy compared to computed tomography in the detection of regional metastases in the clinically negative neck. Int J Radiat Oncol Biol Phys 40: 1027-1032.
39. Wahl RL (1996) Targeting glucose transporters for tumor imaging: "sweet" idea, "sour" result. J Nucl Med 37: 1038-1041.
40. Stokkel MP, Terhaard CH, Hordijk GJ, van Rijk PP (1999) The detection of local recurrent head and neck cancer with fluorine-18 fluorodeoxyglucose dual-head positron emission tomography. Eur J Nucl Med 26: 767-773.
41. Terhaard CH, Bongers V, van Rijk PP, Hordijk GJ (2001) F-18-Fluoro-deoxy-glucosepositron-emission tomography scanning in detection of local recurrence after radiotherapy for laryngeal/pharyngeal cancer. Head Neck 23: 933-941.
42. Gourin CG, Watts TL, Williams HT, Patel VS, Bilodeau PA, Coleman TA (2008) Identification of distant metastases with positron-emission tomography-computed tomography in patients with previously untreated head and neck cancer. Laryngoscope 118: 671-675.
43. Krabbe CA, Pruim J, Dijkstra PU, Balink H, van der Laan BF, de Visscher JG, Roodenburg JL (2009) 18F-FDG PET as a routine posttreatment surveillance tool in oral and oropharyngeal squamous cell carcinoma: a prospective study. J Nucl Med 50: 1940-1947.
44. Isles MG, McConkey C, Mehanna HM (2008) A systematic review and meta-analysis of the role of positron emission tomography in the follow up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapy. Clin Otolaryngol 33: 210-222.
45. Kao J, Vu HL, Genden EM, Mocherla B, Park EE, Packer S, Som PM, Kostakoglu L (2009) The diagnostic and prognostic utility of positron emission tomography/computed tomography-based follow-up after radiotherapy for head and neck cancer. Cancer 115: 4586-4594.
46. Oliver C, Muthukrishnan A, Mountz J, Deeb E, Johnson J, Deleyiannis F (2008) Interpretability of PET/CT imaging in head and neck cancer patients following composite mandibular resection and osteocutaneous free flap reconstruction. Head Neck 30: 187-193.
47. Wolfensberger M, Albrecht S, Müller W, Zbären P, Dulguerov P, Arnoux A, Schmid S (2000) Follow-up after histologically verified radical resection of early cancers of the mouth cavity: results of a prospective multicenter study. Schweiz Med Wochenschr Suppl 116: 12S-14S.
48. Shingaki S, Kobayashi T, Suzuki I, Kohno M, Nakajima T (1995) Surgical treatment of stage I and II oral squamous cell carcinomas: analysis of causes of failure. Br J Oral Maxillofac Surg 33: 304-308.
49. Seitz O, Chambron-Pinho N, Middendorp M, Sader R, Mack M, Vogl TJ, Bisdas S (2009) 18F-Fluorodeoxyglucose-PET/CT to evaluate tumor, nodal disease, and gross tumor volume of oropharyngeal and oral cavity cancer: comparison with MR imaging and validation with surgical specimen. Neuroradiology 51: 677-686.
50. Nahmias C, Lemmens C, Faul D, Carlson E, Long M, Blodgett T, Nuyts J, Townsend D (2008) Does reducing CT artifact from dental implants influence the PET interpretation in PET/CT studies of oral cancer and head and neck cancer? J Nucl Med 49: 1047-1052.
51. Medina JE (1996) Clinical practice guidelines for the diagnosis and management of cancer of the head and neck. American Society for Head and Neck Surgery, Society of Head and Neck Surgeons, Pittsburgh, PA.
52. O'Brien CJ, Traynor SJ, McNeil E, McMahon JD, Chaplin JM (2000) The use of clinical criteria alone in the management of the clinically negative neck among patients with squamous cell carcinoma of the oral cavity and oropharynx. Arch Otolaryngol Head Neck Surg 126: 360-365.
53. Nakayama E, Yoshiura K, Yuasa K, Kanda S, Saitoh M, Kage W, Ikebe T, Ozeki S, Shinohara M (2000) A study of the association between the prognosis of carcinoma of the mandibular gingiva and the pattern of bone destruction on computed tomography. Dentomaxillofac Radiol 29: 163-169.
54. BAO-HNS (2002) Effective head and neck cancer management. 3rd consensus document. British Association of Otorhinolaryngologists. Head and Neck Surgeons Royal College of Surgeons of England, London.
55. Pathak KA, Gupta S, Talole S, Khanna V, Chaturvedi P, Deshpande MS, Pai PS, Chaukar DA, D'Cruz AK (2005) Advanced squamous cell carcinoma of lower gingivobuccal complex: patterns of spread and failure. Head Neck 27: 597-602.
56. Rath GK, Vora Amish, Rajan B, Parikh PM, Kumar S, Sharma GN, Malhotra H, Kumar P, Chaudhry K (2010) Guidelines for management of buccal mucosa cancer: Indian Council of Medical Research New Delhi-110029.
57. Collan J, Lundberg M, Vaalavirta L, Bäck L, Kajanti M, Mäkitie A, Tenhunen M, Saarilahti K (2011) Patterns of relapse following surgery and postoperative intensity modulated radiotherapy for oral and oropharyngeal cancer. Acta Oncol 50: 1119-1125.